Patrick K. Dorr
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 9
- HIV Research and Treatment 9
-
- HIV/AIDS drug development and treatment 7
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Manos Perros (7 shared papers)Mike Westby (4 shared papers)Caroline Smith‐Burchnell (2 shared papers)Julie Mori (2 shared papers)Anthony Wood (2 shared papers)Malcolm J. Macartney (2 shared papers)Carolyn M. Napier (2 shared papers)Paul Griffin (2 shared papers)
- Journals
- Antiviral Research (1 paper)Expert Opinion on Drug Discovery (1 paper)Genome Medicine (1 paper)JAMA Network Open (1 paper)Nature Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Patrick K. Dorr
20 papers receiving 1.5k citations
Patrick K. Dorr's Hit Papers
Peers
Comparison fields: 5 of 91
- Virology 895
- Infectious Diseases 633
- Immunology 304
- Hepatology 81
- Oncology 156
Countries citing papers authored by Patrick K. Dorr
This map shows the geographic impact of Patrick K. Dorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick K. Dorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick K. Dorr more than expected).
Fields of papers citing papers by Patrick K. Dorr
This network shows the impact of papers produced by Patrick K. Dorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick K. Dorr. The network helps show where Patrick K. Dorr may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick K. Dorr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Hit paper breakdown → | 2005 | 965 |
| 2 | 2006 | 290 | |
| 3 | 2003 | 70 | |
| 4 | 1989 | 47 | |
| 5 | 2023 | 47 | |
| 6 | 2010 | 36 | |
| 7 | 2005 | 24 | |
| 8 | 2022 | 22 | |
| 9 | 2008 | 15 | |
| 10 | 2024 | 15 | |
| 11 | 2009 | 14 | |
| 12 | 2019 | 11 | |
| 13 | 2011 | 8 | |
| 14 | 2020 | 4 | |
| 15 | 2007 | 3 | |
| 16 | 1993 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2007 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2024 | 1 |
About Patrick K. Dorr
Patrick K. Dorr is a scholar working on Virology, Infectious Diseases, Immunology, Hepatology and Epidemiology, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers), Immune Cell Function and Interaction (7 papers), Hepatitis C virus research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Hepatitis B Virus Studies (2 papers), Photosynthetic Processes and Mechanisms (1 paper) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Virology (895 citations), Infectious Diseases (633 citations), Immunology (304 citations), Hepatology (81 citations) and Oncology (156 citations). Patrick K. Dorr has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Manos Perros, Mike Westby, Caroline Smith‐Burchnell, Julie Mori, Anthony Wood, Malcolm J. Macartney, Carolyn M. Napier, Paul Griffin, Blanda Stammen and Rob Webster. Their work appears in journals such as Antiviral Research, Expert Opinion on Drug Discovery, Genome Medicine, JAMA Network Open and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.